Built relationships across small medium and large pharma clients in Medical, Commercial, and Clinical to scope, design and execute projects from disease state landscaping to HCP engagement launch strategy. Utilized complex real-world evidence and claims data to define, target, and segment HCPs and patients based on primary and secondary research criteria.Designed and implemented medical impact dashboards that effectively and compliantly track HCP/KOL uptake of key medical themes and any associated change in clinical behaviors.Broad experience across therapeutic areas: Oncology (NSCLC, Breast, Prostate, MCL/CLL), Cardiometabolic disease (Diabetes, Obesity, ASCVD), Immunology (IBD, Atopic Dermatitis), Neuroscience (Alzheimer’s, Parkinson’s), and Rare Disease (SMA, DMD)

At ZS, I worked in a matrixed environment with projects across the R&D/Commercial landscape for life science companies, from the first launch to market research for mature commercial products.Projects include:Clinical Trial Study Planning and OptimizationQualitative market researchMedical Affairs KOL engagement strategy Commercial launch strategy for emerging pharmaClinical Supply Chain development strategy

Focused on understanding thermogenic adipose tissue integrating biochemical mechanisms with animal physiology.

Investigated how thermogenic adipose tissue could be used therapeutically to target metabolic syndrome and related disorders.

Continued graduate research, uncovering the biochemical mechanisms of skeletal muscle and brown adipose tissue mitochondrial metabolism.

Used biochemical, cellular, and animal models to uncover the role of mitochondrial proteins governing temperature regulation in response to various thermogenic stimuli.

Worked to understand how mitochondrial sphingolipid metabolism regulated diverse outcomes in the failing heart and after brain injury.